文献速递免疫规划

缺失c-di-GMP代谢基因的两株rBCG激发的免疫应答影响对不同毒力结核分枝杆菌攻击的保护作用

Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.
PubMed 文献 · Vaccine · 2018-03-15

本研究以活疫苗牛分枝杆菌BCG为对象,探究缺失c-di-GMP代谢相关基因(BCG1419c或BCG1416c)后与巨噬细胞相互作用、在小鼠细胞系和小鼠中诱导免疫应答的变化,以及表面菌膜生长时蛋白谱的改变。结果显示缺失BCG1419c或BCG1416c改变小鼠巨噬细胞TNF-α、IL-6和IL-1β产生并减弱胞内复制,缺失BCG1416c增加CD4+和CD8+ T细胞活化;所有受试BCG菌株接种对高毒力M. tuberculosis 5186致死性攻击提供保护,BCGΔBCG1419c接种在慢性感染晚期(攻击后4至6个月)控制肺部低毒力M. tuberculosis H37Rv生长。

要点

  • 缺失BCG1419c或BCG1416c改变小鼠巨噬细胞TNF-α、IL-6和IL-1β产生并减弱胞内复制。
  • 缺失BCG1416c增加CD4+和CD8+ T细胞活化。
  • 所有受试BCG菌株接种对高毒力M. tuberculosis 5186致死性攻击提供保护。

核心结论

  • 缺失c-di-GMP代谢基因的rBCG改变巨噬细胞因子产生和胞内复制,并影响对不同毒力结核分枝杆菌攻击的保护作用。

研究设计与样本

  • 以活疫苗牛分枝杆菌BCG为对象,构建缺失BCG1419c(ΔPDE)或BCG1416c(ΔDGC)基因的rBCG,评估与巨噬细胞相互作用、在小鼠细胞系和小鼠中诱导免疫应答及表面菌膜生长时蛋白谱改变。

主要发现

  • 缺失BCG1419c或BCG1416c改变小鼠巨噬细胞TNF-α、IL-6和IL-1β产生,并减弱胞内复制。
  • 缺失BCG1416c增加CD4+和CD8+ T细胞活化。
  • 所有受试BCG菌株接种对高毒力M. tuberculosis 5186致死性攻击提供保护。
  • BCGΔBCG1419c接种在攻击后4至6个月慢性感染晚期控制肺部低毒力M. tuberculosis H37Rv生长。
  • 与BCG野生型相比,两株rBCG以表面菌膜生长时改变DnaK、HbhA、PstS2、35KDa抗原、GroEL2及AcpM等抗原蛋白表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pellicles, a type of biofilm, have gathered a renewed interest in the field of tuberculosis as a structure that mimics some characteristics occurring during M. tuberculosis infection, such as antibiotic recalcitrance and chronicity of infection, and as a source of antigens for humoral response in infected guinea pigs. In other bacteria, it has been well documented that the second messenger c-di-GMP modulates the transition from planktonic cells to biofilm formation. In this work, we used the live vaccine Mycobacterium bovis BCG to determine whether deletion of genes involved in c-di-GMP metabolism would affect interaction with macrophages, capacity to induce immune response in a murine cell line and mice, and how the protein profile was modified when grown as surface pellicles. We found that deletion of the BCG1419c (Delta c-di-GMP phosphodiesterase, ΔPDE) gene, or deletion of the BCG1416c (Delta c-di-GMP diguanylate cyclase, ΔDGC) gene, altered production of TNF-α, IL-6, and IL-1β, in murine macrophages, and resulted in attenuation in intra-macrophage replication. Moreover, in addition to the improved immunogenicity of the BCGΔBCG1419c mutant already reported, deletion of the BCG1416c gene leads to increased T CD4+ and T CD8+ activation. This correlated with protection versus lethality in mice infected with the highly virulent M. tuberculosis 5186 afforded by vaccination with all the tested BCG strains, and controlled the growth of the mildly virulent M. tuberculosis H37Rv in lungs by vaccination with BCGΔBCG1419c during chronic late infection from 4 to 6 months after challenge. Furthermore, when grown as surface pellicles, a condition used to manufacture BCG vaccine, in comparison to BCG wild type, both rBCGs changed expression of antigenic proteins such as DnaK, HbhA, PstS2, 35KDa antigen, GroEL2, as well as AcpM, a protein involved in synthesis of mycolic acids, molecules relevant to modulate inflammatory responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Segura-Cerda CA, Aceves-Sánchez MJ, Marquina-Castillo B, et al. Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence. Vaccine. 2018. PMID: 29550192. doi:10.1016/j.vaccine.2018.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。